Cubist Pharmaceuticals, Inc. (CBST) Tops Q3 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jefferies Raises Price Target on Cubist (CBST) to $55
October 19, 2012 9:53 AM EDTJefferies reiterated a Buy rating on Cubist Pharmaceuticals (NASDAQ: CBST) and raised its price target to $55.00 (from $52.00).
Cubist it has 3 products in Ph3 development and analyst said they believe the stock is attractive based on the pipeline products potential.... More
